Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4551711011 | Lisocabtagene maraleucel | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4551712016 | Lisocabtagene maraleucel (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lisocabtagene maraleucel | Is a | Genetically modified T-cell | true | Inferred relationship | Existential restriction modifier | ||
| Lisocabtagene maraleucel | Is a | Antineoplastic agent | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing lisocabtagene maraleucel (medicinal product) | Has active ingredient | True | Lisocabtagene maraleucel | Inferred relationship | Existential restriction modifier | 1 |
| Product containing only lisocabtagene maraleucel (medicinal product) | Has active ingredient | True | Lisocabtagene maraleucel | Inferred relationship | Existential restriction modifier | 1 |
| Product containing lisocabtagene maraleucel in parenteral dose form (medicinal product form) | Has active ingredient | True | Lisocabtagene maraleucel | Inferred relationship | Existential restriction modifier | 1 |
| Product containing only lisocabtagene maraleucel in parenteral dose form (medicinal product form) | Has active ingredient | True | Lisocabtagene maraleucel | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets
FHIR